Literature DB >> 2871307

HTLV-I associated myelopathy, a new clinical entity.

M Osame, K Usuku, S Izumo, N Ijichi, H Amitani, A Igata, M Matsumoto, M Tara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2871307     DOI： 10.1016/s0140-6736(86)91298-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  673 in total

1.  Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.

Authors:  K Araki; K Harada; K Nakamoto; M Shiroma; T Miyakuni
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Interaction of Gli2 with CREB protein on DNA elements in the long terminal repeat of human T-cell leukemia virus type 1 is responsible for transcriptional activation by tax protein.

Authors:  S Dan; A Tanimura; M Yoshida
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.

Authors:  B Kobe; R J Center; B E Kemp; P Poumbourios
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Anti-Rex aptamers as mimics of the Rex-binding element.

Authors:  S Baskerville; M Zapp; A D Ellington
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana.

Authors:  D Moynet; J F Pouliquen; D Londos-Gagliardi; R P Buigues; J F Moreau; I Bedjabaga; M C Georges; A Talarmin; M Joubert; H Fleury; P Vincendeau; B Guillemain
Journal:  Virus Genes       Date:  2001-12       Impact factor: 2.332

6.  Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.

Authors:  Ryuji Kubota; Samantha S Soldan; Roland Martin; Steven Jacobson
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

7.  Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

Authors:  J M Johnson; C Nicot; J Fullen; V Ciminale; L Casareto; J C Mulloy; S Jacobson; G Franchini
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 8.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

9.  Two major subgroups of human T-cell leukemia virus-1 in Japan.

Authors:  H Siomi; T Nosaka; T Saida; H Miwa; Y Hinuma; S Shirakawa; N Miyamoto; T Kondo; K Araki; M Ichimaru
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

10.  Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.

Authors:  Dustin Edwards; Risaku Fukumoto; Maria Fernanda de Castro-Amarante; Luiz Carlos Junior Alcantara; Bernardo Galvão-Castro; Robyn Washington Parks; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.